Latest Quarterly Reporting News

Oceana Metals Limited has completed trenching at its Solonopole Project in Brazil and is progressing technical reviews of its Australian assets, while a strategic rebrand and board refresh signal a new phase for the company.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Carma Limited has reported a surge in vehicle sales and revenue in its latest quarterly report, alongside a successful $100 million IPO that strengthens its growth trajectory.

Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.

Mustera Property Group reports strong sales momentum with $15.05 million contracted at its Verse on McCabe development, alongside a $3 million settlement at Forbes Residences, setting the stage for construction to begin in Q2 2026.

Klevo Rewards Limited has responded to ASX inquiries about a recent spike in its share price and trading volume, attributing the movement to a positive quarterly report and confirming full compliance with disclosure rules.

Wrkr Ltd has transitioned from development to deployment, launching key products and acquiring PaidRight to expand its payroll compliance offerings ahead of new legislation.

Cue Energy Resources reports steady production and a strong cash position, advancing long-term gas contracts in Australia with new drilling planned. Key developments in Indonesia and New Zealand also shape the company’s near-term outlook.

Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.

Far East Gold’s December quarter report highlights significant high-grade gold discoveries at its Idenburg Project and a key regulatory approval that paves the way for accelerated development.

Elixinol Wellness Ltd reported a 9.5% revenue increase in Q4 FY25 alongside a 30% cut in operating costs, achieving its first underlying operating cash flow positive quarter. The company’s strategic acquisitions and e-commerce growth underpin a clear path to profitability.

Nickel Industries reported a 57% drop in quarterly EBITDA due to mining quota delays but showcased robust HPAL margins and advanced commissioning at its Excelsior project, supported by a strategic investment from Sphere Corp.